Aktis Oncology, Inc.(AKTS)
$16.31+0.15 (+0.93%)
AKTS
Aktis Oncology, Inc. hedge funds
$16.31
At close:+0.15 (+0.93%)
Want to see AKTS full AI Analyst Report?
Aktis Oncology, Inc. (AKTS) Hedge Fund Trading Activity
43 Followers
Trend: ▼ Hedge Funds Decreased Holdings by 172.4K Shares Last Quarter
Hedge Fund Holdings in AKTS
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Woodline Partners LP | Added | 72.61% | $3,360,678 | 0.01% | |||
| Added | 22.05% | $54,141,105 | <0.01% | ||||
| Baker Bros Advisors LP | Not Changed | 0.00% | $19,398,954 | 0.10% | |||
| Soros Fund Mangment LLC | Sold Out | -100.00% | $0 | 0.00% | |||
| RA Capital Management | Sold Out | -100.00% | $0 | 0.00% |
FAQ
Which hedge funds hold Aktis Oncology, Inc.?
The hedge funds that hold the most shares in Aktis Oncology, Inc. are BlackRock, Inc., Michael Rockefeller and Peter Kolchinsky.
Are hedge funds buying or selling AKTS?
In the last quarter hedge funds have Decreased their holdings in Aktis Oncology, Inc. by 172.4K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Aktis Oncology, Inc. stock?
Warren Buffet currently does not own shares in Aktis Oncology, Inc..
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here

